Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to the antibody drug conjugate sacituzumab govitecan

ABSTRACT: Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to the antibody drug conjugate sacituzumab govitecan

PROVIDER: PRJNA754210 | ENA |

REPOSITORIES: ENA